Form 4 for BDSX BIODESIX INC
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-21 · accession 0000905148-24-001615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-05-23 | 2024-05-23 | BDSX | Strobeck Matthew | Dir | M - OptEx | — | +347.8K | 2.57M | +16% | — |
| DM | 2024-05-23 | 2024-05-21 | BDSX | Strobeck Matthew | Dir | A - Grant | $0.00 | +90.8K | 53.7K | New | $0 |
| DMI | 2024-05-23 | 2024-05-23 | BDSX | Strobeck Matthew | Dir | M - OptEx | $0.00 | -8,696 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-23 | M | A | 52,160 | — | 85,673 | I By Birchview Capital Separately Managed Account | — | — | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. (F2) The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2024-05-23 | M | A | 295,680 | — | 2,570,879 | I By Birchview Fund LLC | — | — | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. (F2) The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-05-21 | A | A | 37,050 | $0.00 | 37,050 | D By Birchview Fund LLC | $1.57 · — to 2034-05-20 | 37,050 Common Stock | (F2) The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F8) This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. |
| 4 | Derivative | Restricted Stock Units | 2024-05-21 | A | A | 53,726 | $0.00 | 53,726 | D By Birchview Capital Separately Managed Account | — · — to — | 53,726 Common Stock | (F7) Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. (F2) The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F5) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock. (F6) These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. |
| 5 | Derivative | Series A Non-Voting Convertible Preferred Stock | 2024-05-23 | M | D | 7,392 | $0.00 | 0 | I | — · — to — | 295,680 Common Stock | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. |
| 6 | Derivative | Series A Non-Voting Convertible Preferred Stock | 2024-05-23 | M | D | 1,304 | $0.00 | 0 | I | — · — to — | 52,160 Common Stock | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. |